Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
philip.drennan@st-hildas.ox.ac.uk

Research groups

Fullerton Group | Translational Pharmacology

Philip Drennan

Senior Clinical Research Fellow in Clinical Therapeutics

Recent publications

Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response.

Drennan PG. et al, (2025), Lancet Microbe, 6

Immunogenicity of MVA-BN Vaccine Deployed as Mpox Prophylaxis: A Prospective Cohort Study and Analysis of Transcriptomic Predictors of Response

Drennan PG. et al, (2024)

Mycobacterium Tuberculosis Transmission in Birmingham, UK, 2009-19: A Prospective Observational Study

Walker TM. et al, (2023)

In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review.

Drennan PG. et al, (2023), Clin Transl Sci, 16, 357 - 382

In vivo human keyhole limpet haemocyanin challenge in early phase drug development: A systematic review

Drennan P. et al, (2022), Clinical and Translational Science

More publications